首页> 外文OA文献 >A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

【2h】

A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

机译：R1507的第2阶段试验，一种针对胰岛素样生长因子-1受体（IGF-1R）的单克隆抗体，用于复发性或难治性横纹肌肉瘤，骨肉瘤，滑膜肉瘤和其他软组织肉瘤患者：肉瘤联盟的结果通过协作研究进行研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Pappo Alberto S.; Vassal Gilles; Crowley John J.; Bolejack Vanessa; Hogendoorn Pancras C. W.; Chugh Rashmi; Ladanyi Marc; Grippo Joseph F.; Dall Georgina; Staddon Arthur P.; Chawla Sant P.; Maki Robert G.; Araujo Dejka M.; Geoerger Birgit; Ganjoo Kristen; Marina Neyssa; Blay Jean‐yves; Schuetze Scott M.; Chow Warren A.; Helman Lee J.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study [J] . Pappo Alberto S., Vassal Gilles, Crowley John J., Cancer: A Journal of the American Cancer Society . 2014 ,第16期

机译：R1507的相2试验，胰岛素样生长因子-1受体（IGF-1R）的单克隆抗体，患者复发或难治性横纹肌肉瘤，骨肉瘤，滑膜肉瘤和其他软组织肉瘤的肉瘤联盟的患者通过协作研究研究
2. R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study. [J] . Pappo AS, Patel SR, Crowley J, Journal of Clinical Oncology . 2011 ,第34期

机译：R1507是胰岛素样生长因子1受体的单克隆抗体，在复发或难治的尤因肉瘤家族肿瘤患者中：通过合作研究进行的II期肉瘤研究联盟的结果。
3. Phase II study of sequential gemcitabine followed by docetaxel for recurrent ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: Results of sarcoma alliance for research through Collaboration study 003 [J] . FoxE., PatelS., WathenJ.K., The oncologist . 2012 ,第3期

机译：序贯吉西他滨联合多西他赛治疗复发性尤因肉瘤，骨肉瘤或无法切除或局部复发的软骨肉瘤的II期研究：通过协作研究003的肉瘤联盟研究结果
4. Prognosis factors in muscle-skeletal tumors (Osteosarcomas and soft tissue sarcomas) [C] . MILENA ADINA MAN, DANA ALEXANDRESCU, DANA BADAU WSEAS International Conferences . 2009

机译：肌肉骨骼肿瘤预后因素（骨肉瘤和软组织肉瘤）
5. R1507 a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study [O] . Alberto S. Pappo, Shreyaskumar R. Patel, John Crowley, -1

机译：R1507胰岛素样生长因子1受体的单克隆抗体在复发性或难治性尤文氏肉瘤家族患者中：II期肉瘤联盟通过协作研究进行研究的结果
6. R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis [O] . Huang, Helen J., Angelo, Laura S., Rodon, Jordi, 2011

机译：R1507，一种抗胰岛素样生长因子-1受体（IGF-1R）抗体，和尤因氏肉瘤中的EWS / FLI-1 siRNA：在IGF / IGFR / Akt轴上的收敛

著录项

相似文献

相关主题

期刊订阅